Brian Taylor Slingsby - Director, 10%+ Owner at Mineralys Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Director, 10%+ Owner
Issuer Symbol: MLYS on Nasdaq
All Insider Reports: All Insider Reports

Brian Taylor Slingsby - trading volume in the past year for Mineralys Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys	+259,259	21%	$13.50	+$3,499,996
Sells	-1,000,000	79%	$43.35	-$43,350,000
Net	-740,741	-59%		-$39,850,004

Holdings reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Security	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	7,910,038	$271,156,102	$34.28	19 Feb 2026	Indirect
Common Stock	0	$0	$34.28	19 Feb 2026	Direct
Stock Option	8,300			19 Feb 2026	Indirect	Common Stock
Stock Option	0			19 Feb 2026	Direct	Common Stock

Transactions reported by Brian Taylor Slingsby for Mineralys Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.